137 related articles for article (PubMed ID: 18334117)
1. [Application of SELDI-TOF serum proteome profiling in cervical squamous cell carcinoma].
Xia T; Zheng ZG; Gao Y; Mou HZ; Xu SH; Zhang P; Zhu JQ
Ai Zheng; 2008 Mar; 27(3):279-82. PubMed ID: 18334117
[TBL] [Abstract][Full Text] [Related]
2. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
Zhang GQ; Du J; Pang D
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
[TBL] [Abstract][Full Text] [Related]
3. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics.
Zhou L; Cheng L; Tao L; Jia X; Lu Y; Liao P
Acta Otolaryngol; 2006 Aug; 126(8):853-60. PubMed ID: 16846929
[TBL] [Abstract][Full Text] [Related]
4. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
[TBL] [Abstract][Full Text] [Related]
5. [Surface enhanced laser desorption/ionization time-of-flight mass spectrometry profiling of serum in detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis].
Cheng L; Zhou L; Tao L; Zhang M; Cui JF; Liu YK
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2526-30. PubMed ID: 18067823
[TBL] [Abstract][Full Text] [Related]
6. SELDI-TOF MS profiling of serum for detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis.
Cheng L; Zhou L; Tao L; Zhang M; Cui J; Li Y
J Cancer Res Clin Oncol; 2008 Jul; 134(7):769-76. PubMed ID: 18202856
[TBL] [Abstract][Full Text] [Related]
7. [Proteinchip-flight mass spectrometry for screening differentially expressed proteins in the serum of cervical cancer patients].
Cai SN; Liu GB; Guo XH; Chen JG; Zhang J; Wu YL; Liang WJ; Luo RC
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):32-5. PubMed ID: 19218106
[TBL] [Abstract][Full Text] [Related]
8. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.
Lu HB; Zhou JH; Ma YY; Lu HL; Tang YL; Zhang QY; Zhao CH
Jpn J Clin Oncol; 2010 Apr; 40(4):336-42. PubMed ID: 20089528
[TBL] [Abstract][Full Text] [Related]
9. [Application of SELDI-TOF MS technology analyzing serum protein profiling for distinguishing laryngeal carcinoma from ordinary people].
Zhang X; Chen Y; Wang J; Qu X; Deng B; Wang J; Xie G; Li M; Xu F
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Sep; 20(18):842-6. PubMed ID: 17144495
[TBL] [Abstract][Full Text] [Related]
10. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
Liu XP; Shen J; Li ZF; Yan L; Gu J
Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of serum proteomic profiling before and after cervical cancer surgery].
Shao ZY; Zheng ZG; Lou HM; Zhang P
Zhonghua Fu Chan Ke Za Zhi; 2009 May; 44(5):374-8. PubMed ID: 19573315
[TBL] [Abstract][Full Text] [Related]
12. [Serum proteomic spectra of esophageal squamous cell carcinoma patients analyzed with IMAC3 protein chip].
Liu CZ; Zhu PY; Shi MX; Liu JB; Liao P; Xiang CQ; Zhang YX; Wang WJ
Ai Zheng; 2008 Mar; 27(3):272-8. PubMed ID: 18334116
[TBL] [Abstract][Full Text] [Related]
13. [Serum diagnosis of head and neck squamous cell carcinoma using surface-enhanced desorption ionization mass spectrometry and artificial neural network analyses].
Cao SM; Guo X; Chen FJ; Yang AK; Chen WK; Li NW
Ai Zheng; 2007 Jul; 26(7):767-70. PubMed ID: 17626756
[TBL] [Abstract][Full Text] [Related]
14. [Use of laser capture microdissection and surface-enhanced laser desorption ionization time-of-flight mass spectrometry to screen differential proteins in lung adenocarcinoma and lung squamous carcinoma].
Tian YX; Yang SY; Nan YD; Zhang W; Zhou B; Bu LN; Huo SF; Yu JK; Zheng S
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):145-8. PubMed ID: 18361807
[TBL] [Abstract][Full Text] [Related]
15. Application of SELDI-TOF in N-glycopeptides profiling of the urine from patients with endometrial, ovarian and cervical cancer.
Mu AK; Lim BK; Aminudin N; Hashim OH; Shuib AS
Arch Physiol Biochem; 2016 Jul; 122(3):111-6. PubMed ID: 26849673
[TBL] [Abstract][Full Text] [Related]
16. [Application of SELDI-TOF-MS in establishing a model for predicting radiotherapy response of hypopharyngeal cancers].
Tian WD; Zeng ZY; Yu WB; Li XP
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1282-7. PubMed ID: 20584658
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.
Navaglia F; Fogar P; Basso D; Greco E; Padoan A; Tonidandel L; Fadi E; Zambon CF; Bozzato D; Moz S; Seraglia R; Pedrazzoli S; Plebani M
Clin Chem Lab Med; 2009; 47(6):713-23. PubMed ID: 19426140
[TBL] [Abstract][Full Text] [Related]
18. Discrimination analysis of mass spectrometry proteomics for cervical cancer detection.
Liu C; Pan C; Shen J; Wang H; Yong L; Zhang R
Med Oncol; 2011 Dec; 28 Suppl 1():S553-9. PubMed ID: 21080108
[TBL] [Abstract][Full Text] [Related]
19. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
Geng X; Wang F; Li YG; Zhu GP; Zhang WM
J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
[TBL] [Abstract][Full Text] [Related]
20. Serum biomarker screening for the diagnosis of early gastric cancer using SELDI-TOF-MS.
Li P; Zhang D; Guo C
Mol Med Rep; 2012 Jun; 5(6):1531-5. PubMed ID: 22427025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]